TetraKit Technologies - Join us for an exciting session!

Our CEO and Co-founder, Dr. Matthias Herth, will present during the TME Diagnostics session at Theranostics World Congress on Saturday, January 31st, 2026, from 15:30-17:00.

His presentation will cover halogenated FAPI theranostics featuring fluorine-18, iodine-123/131, and astatine-211.

We look forward to welcoming everyone interested halogenated FAPI theranostics.

February 2, 2026

We are excited to welcome Darja Beyer to our team!

Darja will be joining us as a Senor Translational Scientist and will play a key role in advancing translational radiopharmaceutical research☢️ A warm welcome to our newest team member, Darja! She … Read more

January 30, 2026

Accelerate.EU consortium at TWC

Great to be at the Theranostics World Congress with the Accelerate.EU consortium.We are happy to share the progress made on Astatine-211 and targeted alpha therapies, and to highlight Antero Abrunhosa… Read more

January 28, 2026

Updated website

We’re pleased to share that our website has been updated! Visit tetrakit.com to learn about our growing pipeline and how the TetraKit Platform turns cancer-targeting biomolecules into radiopharmaceu… Read more

Join us for an exciting session!

Connect with us: